Notice ID: e7d8c7da1d574ffdb80c955f827be168Combined Synopsis/Solicitation
Animal Vaccines
Archived on April 11, 2024. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 5:00 PM UTC−04:00
- Posted
- March 13, 2024
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- Small Business Set Aside - Total
- NAICS
- 325414: Biological Product (except Diagnostic) Manufacturing
- Agency
- Department of AgricultureAGRICULTURAL RESEARCH SERVICE
Notice details
- Office
- USDA ARS PA AAO ACQ/PER PROP
- Place of performance
- Clay Center, 68933
- Last updated
- Sep 25, 2026
Identifiers
- Solicitation number
- 12805B24Q0170
- Notice ID
- e7d8c7da1d574ffdb80c955f827be168
Description
This is a combined synopsis/solicitation for commercial item prepared in accordance with the format in FAR subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. The solicitation number is 12805B24Q0170 and is issued as a request for quotation (RFQ). This solicitation document incorporates those provisions and clauses in effect through Federal Acquisition Circular 2024-03. The associated NAICS Code is 325414 Biological Product, and the Small Business Size Standard is 1120 employees. The USDA, Agricultural Research Service, Plains Area, Meat Animal Research Laboratory requires purchase to supply animal vaccines. The Government intends to award a firm fixed price purchase order. Total Small Business Set Aside. The requirements are further detail in the attached Requirements Document. The DELIVERY ADDRESS is: PA U.S. MEAT ANIMAL RESEARCH CENTER P.O. BOX 166, STATE SPUR 18D CLAY CENTER NE DOCUMENTS TO BE INCLUDED IN QUOTE: In order to be considered for award, Offerors shall respond by: Quoter Information: Completed and signed “Quoter Information” (page 1 of this Solicitation). Quote pricing document: Document shall provide detailed pricing breakout in accordance with the CLIN structure and requested per Attach 02 Completed fillable “Schedule of Items” (MS Excel Interactive Document) Have an Active SAM.gov registration and complete the Representations in FAR 52.204-24; the Representation and Certification section should also be completed electronically in the System for Award Management (SAM) at www.sam.gov. Any amendment and documents related to this procurement will be available electronically at the Government Point of Entry (sam.gov). FAR clauses 52.212-1, 52.212-2, 52.212-3, 52.212-4 and 52.212-5 (and any addenda to those clauses) are included in the attached clauses and provisions document. Additionally, other contract requirements and terms/conditions can be located in the same document. The Government anticipates award of a contract resulting from this solicitation to the responsible offeror whose quote conforms to the specifications that will be the most advantageous to the Government in accordance with FAR 13.106-2 considering three major areas: technical acceptance, past performance and price. Quotes will be evaluated by performing a comparative evaluation in accordance with FAR 13.106-2(b)(3) to determine which quote meets the lowest price technically acceptable evaluation methodology. All sources wishing to quote shall furnish a quotation by 5:00 p.m. Eastern Time, on or before March 27, 2024. Quotations are to be sent via email to Connie Faulkner at connie.faulkner@usd.gov. Failure to provide the required information in the requested format may result in quotes not being considered for award. Attached Provisions/Clauses apply to this RFQ and any subsequent award.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
No documents available.
Lifecycle
Solicitation:
12805B24Q0170- Combined Synopsis
- Combined SynopsisCurrentMar 13, 2024
Animal Vaccines
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Influenza Vaccine Solicitation: SPE2DP26R0003 | 75% | Solicitation | 12/03/2026 |
The Defense Logistics Agency Troop Support is soliciting for the supply of Southern Hemisphere Influenza Vaccine for the 2027-2028 flu season. Approximately 30,000 doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.) The vaccines shall be a pre-measured 0.5 ML dose, each dose shall be pre-filled in a commercially available syringe for intramuscular administration in healthy individuals aged 6 months and older. The vaccine shall be U.S. Food & Drug Administration (FDA)-approved and U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommended. The formula for the 2027-2028 season vaccine shall be determined by the FDA’s Vaccines and Related Biological Products Advisory Committee. Other specification data is included in the solicitation. Successful contractor must have FDA Approval and the vaccine must be ACIP recommended. National Stock Numbers shall be established at time of award. An indefinite quantity contract is proposed. The quantity indicated is an annual estimate only. (Quantities may increase or decrease pending receipt of final Service requirements.) The guaranteed minimum will be 75% of the annual estimate, and a contract maximum will be established at 150% of the annual estimate. All quantities shall be delivered to the Defense Depot New Cumberland, PA. The contractor shall be capable of delivering 100% of the requirements by March 12, 2027. This delivery schedule is the preferred delivery schedule. Other delivery schedules will be considered. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://www.sam.gov. Interested parties should contact Rosbert Jones (rosbert.jones@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of presolicitation or solicitation changes through this website. The current projected solicitation date is September 28, 2026, closing on Ocrtober 14, 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date. | 70% | Solicitation | 10/14/2026 |
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79726R0035 for an unrestrictive procurement for the Influenza Virus Vaccine for the Department of Veterans Affairs (VA) to include State Veteran Homes option 2 (SVH2 s), Bureau of Prisons (BOP), Indian Health Service (IHS), and Captain James A. Lovell Federal Health Care Center (FHCC) for the 2027-2028 Influenza Season. Evaluation and award will be made by solicitation line item for VA, BOP, IHS, and FHCC requirements. Offerors are not required to submit an offer for every line item; however, the offeror must offer the full quantity for each line item offered. Additionally, all offered line items for a single presentation must be offered at the same unit price. Please note that the final offered price must include the Cost Recovery Fee (CRF) and Federal Excise Tax (FET). Orders will be placed by and delivered to VA, SVH2, BOP, and IHS facilities throughout the United States, the Philippines and Puerto Rico. The contractor(s) will be required to deliver the vaccine Free On Board (FOB) Destination to Government facilities within the U.S., Philippines, and Puerto Rico. The first shipment of product ordered must be at least 50% of each individual facility s ordered quantity and must be delivered between August 15, 2027, and September 15, 2027. The second shipment must be for the remaining individual facility s entire ordered quantity and must be delivered between September 16, 2027, and October 15, 2027. FHCC shall receive 100% of the awarded quantities between August 15, 2027 and September 15, 2027. Solicitation number 36E79726R0035 is estimated to be electronically issued in commercial item format in accordance with FAR Part 12 on or about September 8, 2026, with a closing date of September 24, 2026. ESTIMATED ANNUAL REQUIREMENTS BY AGENCY PRESENTATION DESCRIPTION PACKAGE TYPE VA EST ANNUAL USAGE BOP EST ANNUAL USAGE IHS EST ANNUAL USAGE FHCC EST ANNUAL USAGE TOTAL ESTIMATED ANNUAL USAGE 1 Influenza Virus Vaccine: Pre-filled single dose syringes with plunger and Luer lock needle attachment, Trivalent or Quadrivalent; 2027-2028 influenza season; latex and preservative free: for persons 36 months. SYRINGE (Box of 10) 120,000 6,129 27,200 550 153,879 2 I Influenza Virus Vaccine: Pre-filled single dose syringe with plunger and Luer lock needle attachment, Trivalent or Quadrivalent; 2027-2028 influenza season; latex and preservative free; must be specifically designed for persons 65 years and older as approved by the FDA. SYRINGE (Box of 10) 110,000 280 11,000 400 121,680 3 Influenza Virus Vaccine: Pre-filled single dose syringe with plunger and Luer lock needle attachment, Trivalent or Quadrivalent; 2027-2028 influenza season. Must be split virus vaccine (subvirion or purified surface antigen) that has been FDA approved and labeled with indications for administration to children 6 months - 35 months of age (pediatric), latex and preservative free. SYRINGE (Box of 10) 0 0 1,000 0 1,000 The final vaccine presentation for each line item (Trivalent or Quadrivalent) shall be based on recommendations issued by WHO. If WHO recommends both Trivalent and Quadrivalent influenza strain presentations, and both are commercially available from the offeror or contract awardee, the Trivalent presentation shall be required. | 69% | Pre-Solicitation | 09/08/2026 |
Fluzone and Flublok Influenza Vaccines for the 2026-2027 Flu season. The vaccine is required to immunize embassy immunocompromised family members. | 68% | Sole Source / J&A | Open |
Egg-Free Influenza Vaccine Solicitation: SPE2DP26R0004 | 68% | Solicitation | 12/03/2026 |
Additional Details
Solicitation Number
12805B24Q0170
Archive Date
Apr 11, 2024
Office Address
FORT COLLINS, CO, 80526